Europlaz enters supply agreement to manufacture consumables for innovative home dialysis system
Essex-based medical device supplier, Europlaz Technologies Ltd., has entered into a new supply agreement to manufacture consumables for a ground-breaking, compact, cartridge-based haemodialysis system called SC+, which was developed by Midlands-based Quanta Dialysis Technologies. This supply agreement crystallises a ten-year development collaboration between Europlaz and Quanta.
SC+ is a small and simple-to-use home dialysis system. SC+ provides greater flexibility around where, when and how we deliver life-sustaining therapies. As a medical device with a CE mark, alongside the NHS, we are able to successfully pilot the SC+. This allows SC+ to be commercially available in the UK, for use in the home, dialysis clinics and hospitals.
John E. Milad, CEO of Quanta Dialysis Technologies, states: “As we put in place final preparations ahead of the commercialisation of SC+ this year. We have been working hard to secure and scale-up our supply chain. We look forward to continuing our work with Europlaz as we enter the next exciting phase of our mission, which is to improve the lives of dialysis patients.”
Eddie O’Keeffe, Chairman of Europlaz Technologies, say “It is a delight that we are able to work with Quanta on their state-of-the-art haemodialysis machine. This advancement in treatment will change the lives of people faced with having to undergo dialysis. I am extremely proud of the work to which the team at Europlaz have contributed. The team has helped the development and commercialisation of this equipment. We look forward to working with Quanta for many years to come as this ground-breaking product has world-wide potential.”